Results 1 to 10 of about 8,882 (195)

Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study

Journal of the American Academy of Dermatology, 2022
Adele Salemme, Luca Fania, Alessandra Scarabello   +2 more
exaly  

A population-based study of the association between bullous pemphigoid and neurologic disorders

Journal of the American Academy of Dermatology, 2014
Rodolfo Savica, Christine M Lohse, Mark R Pittelkow   +2 more
exaly  

Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009

Journal of the American Academy of Dermatology, 2014
Christine M Lohse, Mark R Pittelkow, Julia S Lehman   +2 more
exaly  

The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan

Journal of Dermatological Science, 1995
Shinji Morioka, Y Sasai, Yutaka Inaba
exaly  

Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database

Journal of Clinical Pharmacy and Therapeutics, 2016
Unax Lertxundi
exaly  

Association of bullous pemphigoid and comorbid health conditions: a case–control study

Archives of Dermatological Research, 2020
Sherry Lee, Supriya Rastogi, Derek Y Hsu   +2 more
exaly  

Omalizumab therapy for bullous pemphigoid

Journal of the American Academy of Dermatology, 2014
Kenneth K Yu, Ashley B Crew, Kelly A N Messingham   +2 more
exaly  

Bullous Pemphigoid: Trigger and Predisposing Factors

Biomolecules, 2020
Francesco Moro, Luca Fania, Adele Salemme   +2 more
exaly  

Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid

Journal of the American Academy of Dermatology, 2013
Miklós Sárdy, Rita Varga
exaly  

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Journal of the American Academy of Dermatology, 2018
Michael Benzaquen, , Philippe Berbis
exaly